Literature DB >> 10652601

Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines.

Y Makino1, H Sakagami, M Takeda.   

Abstract

Sodium-L-ascorbate, L-ascorbic acid, D-isoascorbic acid, sodium 5,6-benzylidene-L-ascorbate and sodium-6-beta-O-galactosyl-L-ascorbate, which produce ascorbyl radicals during the oxidative degradation, also induced cytotoxicity against cultured human renal carcinoma (TC-1) and glioblastoma multiform tumor (T98G) cell lines. On the other hand, L-ascorbic acid 2-phosphate magnesium and L-ascorbic acid 2-sulfate dipotassium salt, which do not produce the ascorbyl radical, were inactive. This suggests the possible role of the ascorbyl radical for cell death induction. T98G cells were more resistant to ascorbate analogs than TC-1 and HL-60 cells, possibly due to higher intracellular glutathione concentrations. Ascorbate treatment induced rapid elevation of both intracellular concentration of cAMP and Ca2+ in HL-60 cells, but not in TC-1 and T98G cells. However, the elevation of cAMP by theophyline and N,2-dibutyryl adenosine 3,5 cyclic monophosphate (dibutyryl cAMP) resulted in a decrease in the viable cell number. This suggests the possible role of cAMP for ascorbate-induced cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10652601

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Nitric oxide modulates sodium vitamin C transporter 2 (SVCT-2) protein expression via protein kinase G (PKG) and nuclear factor-κB (NF-κB).

Authors:  Camila Cabral Portugal; Thaísa Godinho da Encarnação; Renato Socodato; Sarah Rodrigues Moreira; Dan Brudzewsky; António Francisco Ambrósio; Roberto Paes-de-Carvalho
Journal:  J Biol Chem       Date:  2011-10-31       Impact factor: 5.157

2.  Antiproliferative and apoptotic effect of ascorbyl stearate in human glioblastoma multiforme cells: modulation of insulin-like growth factor-I receptor (IGF-IR) expression.

Authors:  K A Naidu; J L Tang; K A Naidu; L D Prockop; S V Nicosia; D Coppola
Journal:  J Neurooncol       Date:  2001-08       Impact factor: 4.130

3.  The prospects of vitamin C in cancer therapy.

Authors:  Wang-Jae Lee
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

4.  Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.

Authors:  Alan J Wright; Greg A Fellows; John R Griffiths; M Wilson; B Anthony Bell; Franklyn A Howe
Journal:  Mol Cancer       Date:  2010-03-23       Impact factor: 27.401

5.  Vitamin C in human health and disease is still a mystery? An overview.

Authors:  K Akhilender Naidu
Journal:  Nutr J       Date:  2003-08-21       Impact factor: 3.271

6.  Transcriptomic and functional pathways analysis of ascorbate-induced cytotoxicity and resistance of Burkitt lymphoma.

Authors:  Zenglin Pei; Xuan Zhang; Chunxia Ji; Song-Mei Liu; Jin Wang
Journal:  Oncotarget       Date:  2016-09-27

Review 7.  High-Dose Vitamin C in Advanced-Stage Cancer Patients.

Authors:  Anna Zasowska-Nowak; Piotr Jan Nowak; Aleksandra Ciałkowska-Rysz
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

8.  A RCT Testing If a Storybook Can Teach Children About Home Safety.

Authors:  Barbara A Morrongiello; Alexandra R Marquis; Amanda Cox
Journal:  J Pediatr Psychol       Date:  2021-08-11

9.  Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.

Authors:  Christopher M Stephenson; Robert D Levin; Thomas Spector; Christopher G Lis
Journal:  Cancer Chemother Pharmacol       Date:  2013-05-14       Impact factor: 3.333

10.  Novel halogenated 3-deazapurine, 7-deazapurine and alkylated 9-deazapurine derivatives of L-ascorbic or imino-L-ascorbic acid: Synthesis, antitumour and antiviral activity evaluations.

Authors:  Maja Stipković Babić; Damjan Makuc; Janez Plavec; Tamara Martinović; Sandra Kraljević Pavelić; Krešimir Pavelić; Robert Snoeck; Graciela Andrei; Dominique Schols; Karlo Wittine; Mladen Mintas
Journal:  Eur J Med Chem       Date:  2015-08-10       Impact factor: 6.514

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.